Site navigation

Navigation

Motor neurone disease - riluzole

Description

NICE has recommended that riluzole should be available for the treatment of individuals with MND in accordance with its licensed indications. Treatment with riluzole should only be started by a neurological specialist who is experienced in the management of MND. Routine supervision of therapy may ...

Read the complete summary


Guidance documents

Implementing this guidance

  • None available

Other information


About this guidance

Technology appraisals TA20

Issued: January 2001

How this guidance was produced

See also:

See this guidance in practice:

Order printed copies of this guidance